Skip to main content
SpringerLink
Log in

Pleural Tumors

  • Chapter
Lung Pathology

Part of the book series: Current Clinical Pathology ((CCPATH))

  • 2157 Accesses

Abstract

The term mesothelioma has been applied to two very different neoplasms. The first is the diffuse malignant mesothelioma (DMM), which covers the serosal surface, has both epithelioid and mesenchymal characteristics histologically, is virtually always fatal, and is caused by asbestos. The second is the fibrous mesothelioma, which forms a discrete mass, usually can be cured by resection, and is not related to asbestos. It is derived from the submesothelial fibroblast and thus has a histogenesis different from DMM. Its radio- graphic appearance as a baseball in the chest differs dramatically from DMM, but a needle biopsy of the tumor may show hyperchromatic spindle cells difficult to differentiate from a fibrosarcomatous or desmoplastic subtype of DMM.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Readings Solitary Fibrous Tumor of the Pleura

  1. Scharifker D, Kaneko M. Localized fibrous “mesothelioma” of pleura (submesothelial fibroma). A clinicopathologic study of 18 cases. Cancer 1979;43:627–635.

    Article  PubMed  CAS  Google Scholar 

  2. Briselli M, Mark EJ, Dickersin GR. Solitary fibrous tumors of the pleura: eight new cases and review of 360 cases in the literature. Cancer 1981;47:2678–2689.

    Article  PubMed  CAS  Google Scholar 

  3. Keating S, Simon GT, Alexopoulou I, Kay JM. Solitary fibrous tumor of the pleura: an ultrastructural and immunohistochemical study. Thorax 1987;42:976–979.

    PubMed  CAS  Google Scholar 

  4. Westra WH, Gerald WL, Rosai J. Solitary fibrous tumor. Consistent CD34 immunoreactivity and occurrence in the orbit. Am J Surg Pathol 1994;18:992–998.

    PubMed  CAS  Google Scholar 

  5. Van de Rijn M, Lombard CM, Rouse RV. Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum, and lung. Am J Surg Pathol 1994;18:814–820.

    PubMed  Google Scholar 

  6. Carter D, Otis CN. Three types of spindle cell tumors of the pleura. Fibroma, sarcoma, and sarcomatoid mesothelioma. Am J Surg Pathol 1988;12:747–753.

    PubMed  CAS  Google Scholar 

  7. de Saint Aubain Somerhausen N, Rubin BP, Fletcher CD. Myxoid solitary fibrous tumor: a study of seven cases with emphasis on differential diagnosis. Mod Pathol 1999;12:463–471.

    PubMed  Google Scholar 

Diffuse Malignant Mesothelioma

  1. Whitaker D, Henderson DW, Shilkin KB. The concept of mesothelioma in situ: Implications for diagnosis and histogenesis. Sem Diagn Pathol 1992;9:151–161.

    CAS  Google Scholar 

  2. Whitaker D, Shilkin KB. Diagnosis of pleural malignant mesothelioma in life—a practical approach. J Pathol 1984;143:147–175.

    Article  PubMed  CAS  Google Scholar 

  3. MacDougall DB, Wang SE, Zidar BL. Mucin-positive epithelial mesothelioma. Arch Pathol Lab Med 1992;116:874–880.

    PubMed  CAS  Google Scholar 

  4. Sherman ME, Mark EJ. Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma. Arch Pathol Lab Med 1990;114:845–851.

    PubMed  CAS  Google Scholar 

  5. Sussman J, Rosai J. Lymph node metastasis as the initial manifestation of malignant mesothelioma. Report of six cases. Am J Surg Pathol 1990;14:819–828.

    PubMed  CAS  Google Scholar 

  6. Mark EJ, Shin DH. Diffuse malignant mesothelioma of the pleura: a clinicopathological study of six patients with a prolonged symptom-free interval or extended survival after biopsy and a review of the literature of long-term survival. Virchows Archiv A Pathol Anat 1993;422:445–451.

    Article  CAS  Google Scholar 

  7. Okamura H, Kamei T, Mitsuno A, Hongo H, Sakuma N, Ishihara T. Localized malignant mesothelioma of the pleura. Pathol Internat 2001;51:654–660.

    Article  CAS  Google Scholar 

  8. DiMuzio M, Spoletini L, Strizzi L, et al. Prognostic significance of presence and reduplication of basal lamina in malignant pleural mesothelioma. Hum Pathol 2000;31:1341–1345.

    Article  CAS  Google Scholar 

  9. Cappello F, Barnes L. Synovial sarcoma and malignant mesothelioma of the pleura: review, differential diagnosis, and possible role of apoptosis. Pathology 2001;33:142–148.

    Article  PubMed  CAS  Google Scholar 

  10. Hammar SP, Bockus DE, Remington FL. Mucin-positive epithelial neoplasms: a histochemical, immunohistochemical and ultrastructural comparison with mucin-producing pulmonary adenocarcinomas. Ultrastr Pathol 1996;20:293–325.

    CAS  Google Scholar 

  11. Sterman DH, Kaiser LR, Albelda SM. Advances in the treatment of malignant pleural mesothelioma. Chest 1999;116:504–520.

    Article  PubMed  CAS  Google Scholar 

  12. Rees D, Myers JE, Goodman K, et al. Case-control study of mesothelioma in South Africa. Am J Indust Med 1999;35:213–222.

    Article  CAS  Google Scholar 

  13. Krishna J, Haqqani MT. Liposarcomatous differentiation in diffuse pleural mesothelioma. Thorax 1993;48:409–410.

    Article  PubMed  CAS  Google Scholar 

  14. Donna A, Betta PG. Differentiation towards cartilage and bone in a primary tumour of pleura;further evidence in support of the concept of mesodermoma. Histopathology 1986;10:101–108.

    Article  PubMed  CAS  Google Scholar 

  15. Postoloff AV. Mesothelioma of pleura. Arch Pathol 1944;37:286–289.

    Google Scholar 

  16. Donna A, Betta PG. Mesodermomas new embryological approach to primary tumours of coelomic surfaces. Histopathology 1981;5:31–44.

    Article  PubMed  CAS  Google Scholar 

  17. Donna A, Betta PG, Bianchi V, et al. A new insight into the histogenesis of “mesodermomas”—malignant mesotheliomas. Histopathology 1991;19:239–243.

    Article  PubMed  CAS  Google Scholar 

Desmoplastic Diffuse Malignant Mesothelioma

  1. Epstein JI, Budin RE. Keratin and epithelial membrane antigen immunoreactivity in nonneoplastic fibrous pleural lesions: Implications for the diagnosis of desmoplastic mesothelioma. Hum Pathol 1986;17:514–519.

    Article  PubMed  CAS  Google Scholar 

  2. Crotty TB, Colby TV, Gay PC, Pisani RJ. Desmoplastic malignant mesothelioma masquerading as sclerosing mediastinitis: a diagnostic dilemma. Hum Pathol 1992;23:79–82.

    Article  PubMed  CAS  Google Scholar 

  3. Montag AG, Pinkus GS, Corson JM. Keratin protein immunoreactivity of sarcomatoid and mixed types of diffuse malignant mesothelioma. An immunoperoxidase study of 30 cases. Hum Pathol 1988;19:336–342.

    Article  PubMed  CAS  Google Scholar 

  4. Cantin R, Al-Jabi M, McCaughey WT. Desmoplastic diffuse mesothelioma. Am J Surg Pathol 1982;6:215–222.

    PubMed  CAS  Google Scholar 

  5. Flint A, Weiss SW. CD-34 and keratin expression distinguishes solitary fibrous tumor (fibrous mesothelioma) of pleura from desmoplastic mesothelioma. Hum Pathol 1995;26:428–431.

    Article  PubMed  CAS  Google Scholar 

  6. Mangano WE, Cagle PT, Churg A, Vollmer RT, Roggli VL. The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy. Am J Clin Pathol 1998;110:191–199.

    PubMed  CAS  Google Scholar 

Diffuse Malignant Mesothelioma: Immunohistochemistry

  1. Ordonez NG. Role of immunohistochemistry in differentiating epithelial mesothelioma from adenocarcinoma. Am J Clin Pathol 1999;112:75–89.

    PubMed  CAS  Google Scholar 

  2. Oaes J, Edwards C. HMBE-1, MOC-31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma. Histopathol 2000;36:341–347.

    Article  Google Scholar 

  3. Khoor A, Whitsett JA, Stahlman MT, Olson SJ, Cagle PT. Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma. Hum Pathol 1999;30:695–700.

    Article  PubMed  CAS  Google Scholar 

  4. Koukoulis GK, Shen J, Monson R, et al. Pleural mesotheliomas have an integrin profile distinct from visceral carcinomas. Hum Pathol 1997;28:84–90.

    Article  PubMed  CAS  Google Scholar 

  5. Ordonez NG. The immunohistochemical diagnosis of epithelial mesothelioma. Hum Pathol 1999;30:313–323.

    Article  PubMed  CAS  Google Scholar 

  6. Hurlimann J. Desmin and neural marker expression in mesothelial cells and mesotheliomas. Hum Pathol 1994;25:753–757.

    Article  PubMed  CAS  Google Scholar 

  7. Dona A, Betta P-G, Chiodera P, et al. Newly marketed tissue markers for malignant mesothelioma: immunoreactivity of rabbit AMAD-2 antiserum compared with monoclonal antibody HBME-1 and a review of the literature on so-called antimesothelioma antibodies. Hum Pathol 1997;28:929–937.

    Article  Google Scholar 

  8. Sosolik RC, McGaughy VR, De Young BR. Anti-MOC-31: a potential addition to the pulmonary adenocarcinoma versus mesothelioma immunohistochemistry panel. Mod Pathol 1997;10:716–719.

    PubMed  CAS  Google Scholar 

  9. Riera JR, Astengo-Osuna C, Longmate JA, Battifora H. The immunohistochemical diagnostic panel for epithelial mesothelioma. A reevaluation after heat-induced epitope retrieval. Am J Surg Pathol 1997;21:1409–1419.

    Article  PubMed  CAS  Google Scholar 

  10. Dahlstrom JE, Maxwell LE, Brodie N, Zardawi IM, Jain S. Distinctive microvillous brushborder staining with HMBE-1 distinguishes pleural mesotheliomas from pulmonary adenocarcinomas. Pathology 2001;33:287–291.

    Article  PubMed  CAS  Google Scholar 

  11. Robers F, Harper CM, Downie I, Burnett RA. Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma. A study of thirteen antibodies. Am J Clin Pathol 2001;116:253–262.

    Article  Google Scholar 

  12. Comin CE, Novelli L, Boddi V, Paglierani M, Dini S. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma. Hum Pathol 2001;32:529–536.

    Article  PubMed  CAS  Google Scholar 

  13. Kung IT, Thallas V, Spencer EJ, Wilson SM. Expression of muscle actins in diffuse mesotheliomas. Hum Pathol 1995;26:565–570.

    Article  PubMed  CAS  Google Scholar 

  14. Leers MP, Aarts MM, Theunissen PH. E-cadherin and calretinin: a useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma. Histopathology 1998;32:209–216.

    Article  PubMed  CAS  Google Scholar 

Diffuse Malignant Mesothelioma: Recently Described Variants

  1. Chan HT, Yantiss RK, Nielsen GP, McKee GT, Mark EJ. Lipid-rich diffuse malignant mesothelioma: a case report. Hum Pathol 2000;31:876–879.

    Article  Google Scholar 

  2. Shimazaki H, Aida S, Iizuka Y, Yoshizu H, Tamai S. Vacuolated cell mesothelioma of the pericardium resembling liposarcoma: a case report. Hum Pathol 2000;31:767–770.

    Article  PubMed  CAS  Google Scholar 

  3. Ordonez NG, Mackay B. Glycogen-rich mesothelioma. Ultrastruc Pathol 1999;23:401–406.

    Article  CAS  Google Scholar 

  4. Yousem SA, Hochholzer LH. Malignant mesotheliomas with osseous and cartilaginous differentiation. Arch Pathol Lab Med 1987;111:62–66.

    PubMed  CAS  Google Scholar 

  5. Mayall FG, Gibbs AR. The histology and immunohistochemistry of small cell mesothelioma. Histopathol 1992;20:47–51.

    Article  CAS  Google Scholar 

  6. Matsukuma S, Aida S Hata Y, Sugiura Y, Tamai S. Localized malignant peritoneal mesothelioma containing rhabdoid cells. Pathol Internat 1996;46:389–391.

    CAS  Google Scholar 

  7. Nascimento AG, Keeney GL, Fletcher CDM. Deciduoid peritoneal mesothelioma. An unusual phenotype affecting your females. Am J Surg Pathol 1994;18:439–445.

    Article  PubMed  CAS  Google Scholar 

  8. Khalidi HS, Medeiros LJ, Battifora H. Lymphohistiocytoid mesotheliomas. An often misdiagnosed variant of sarcomatoid malignant mesothelioma. Am J Clin Pathol 2000;113:649–654.

    Article  PubMed  CAS  Google Scholar 

  9. Orosz Z, Nagy P, Szentirmay Z, Zalatnai A, Hauser P. Epithelial mesothelioma with deciduoid features. Virchows Archives 1999;434:263–266.

    Article  CAS  Google Scholar 

  10. Shanks J, Harris M, Bannerje E, et al. Mesotheliomas with deciduoid morphology: a morphologic spectrum and a variant not confined to young females. Am J Surg Pathol 2000;24:285–294.

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press, Totowa, NJ

About this chapter

Cite this chapter

(2005). Pleural Tumors. In: Lung Pathology. Current Clinical Pathology. Humana Press. https://doi.org/10.1007/978-1-59259-937-0_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-937-0_10

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-388-6

  • Online ISBN: 978-1-59259-937-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation